Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04146038
Title Salsalate, Venetoclax, and Decitabine or Azacitidine for the Treatment of Acute Myeloid Leukemia or Advanced Myelodysplasia/Myeloproliferative Disease
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Rutgers, The State University of New Jersey

myelodysplastic syndrome

chronic myelomonocytic leukemia

acute myeloid leukemia

myeloproliferative neoplasm


Decitabine + Salsalate + Venetoclax

Azacitidine + Salsalate + Venetoclax

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST